Patents by Inventor Rajender

Rajender has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10457695
    Abstract: The present invention relates to process for preparation of tavaborole with high purity. The present invention relates to method of assessing the purity of tavaborole.
    Type: Grant
    Filed: January 12, 2017
    Date of Patent: October 29, 2019
    Assignee: Glenmark Life Sciences Limited
    Inventors: Srinivasan Subramanian Kuduva, Rajender, Mahendra Joma Choraghe, Samir Naik, Shekhar Bhaskar Bhirud
  • Patent number: 8722665
    Abstract: The present invention provides a compound of general formulae (8a-i), (11a-i), (14a-i), and (17a-i), useful as potential antitumour agents against human cancer cell lines. The present invention further provides a process for the preparation of Cinnamido-pyrrolo[2,1-c][1,4]benzodiazepines of general formulae (8a-i), (11a-i), (14a-i), and (17a-i).
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: May 13, 2014
    Assignee: Council of Scientific & Industrial Research
    Inventors: Kamal Ahmed, Balakishan Gorre, Ramakrishna Gadupudi, Sreekanth Kokkonda, Rajender
  • Patent number: 8383618
    Abstract: The present invention provides a compounds of general formula IXa-d, useful as potential antitumour agents and pharmaceutical composition comprising these compounds exhibits binding affinity with calf thymus (CT) DNA at a molar ratio of 1:5 in aqueous sodium phosphate buffer at pH of 7.00. The present invention further provides a process for the preparation of C2-Fluoro substituted piperazine linked pyrrolo[2,1c][1-4], benzodiazepine of formula (IX).
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: February 26, 2013
    Assignee: Council of Scientific & Industrial Research
    Inventors: Ahmed Kamal, Rajender, Metuku Kashireddy, Gorre Balakishan
  • Publication number: 20110190275
    Abstract: The present invention provides a compounds of general formula IXa-d, useful as potential antitumour agents and pharmaceutical composition comprising these compounds exhibits binding affinity with calf thymus (CT) DNA at a molar ratio of 1:5 in aqueous sodium phosphate buffer at pH of 7.00. The present invention further provides a process for the preparation of C2-Fluoro substituted piperazine linked pyrrolo[2,1c][1-4], benzodiazepine of formula (IX).
    Type: Application
    Filed: October 31, 2008
    Publication date: August 4, 2011
    Inventors: Ahmed Kamal, Rajender, Metuku Kashireddy, Gorre Balakishan